ADMA BIOLOGICS, INC. Unrecognized Tax Benefits, Period Increase (Decrease)
ADMA BIOLOGICS, INC. (ADMA) reported Unrecognized Tax Benefits, Period Increase (Decrease) of $0 for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Notes › Income Taxes
us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease · last filed 2024-05-09
- ADMA BIOLOGICS, INC. unrecognized tax benefits, period increase (decrease) for the quarter ending 2024-03-31 was $0.00.
- ADMA BIOLOGICS, INC. unrecognized tax benefits, period increase (decrease) for the quarter ending 2023-09-30 was $0.00.
- ADMA BIOLOGICS, INC. unrecognized tax benefits, period increase (decrease) for the quarter ending 2023-06-30 was $0.00.
- ADMA BIOLOGICS, INC. unrecognized tax benefits, period increase (decrease) for the quarter ending 2023-03-31 was $0.00.
| Period end | Unrecognized Tax Benefits, Period Increase (Decrease) 3 month | Unrecognized Tax Benefits, Period Increase (Decrease) 6 month | Unrecognized Tax Benefits, Period Increase (Decrease) 9 month |
|---|---|---|---|
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |